Akihiro Mouri - Concepedia

Author

Akihiro Mouri

Meijo University ORCID

Also Known As

A Mouri, A, Mouri, A. Mouri, AKIHIRO MOURI, Akihiro MOURI, Akihiro Mouri, Mouri Akihiro, Mouri, Akihiro

182

Publications

4.7K

Citations

H-Index

158

Concepts

All Affiliations

Meijo University Nagoya University Hospital Nagoya University Fujita Health University Kangwon National University

About

Akihiro Mouri is an author at Meijo University specializing in medicine, neuroscience, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	54	2.5K
2	Health Sciences	5	5	291
3	Natural Sciences	1	1	13
4	Nursing	1	1	11
5	Public Health	1	1	38

Akihiro Mouri

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Blonanserin Ameliorates Phencyclidine-Induced Visual-Recognition Memory Deficits: the Complex Mechanism of Blonanserin Action Involving D3-5-HT2A and D1-NMDA Receptors in the mPFC Hirotake Hida, Akihiro Mouri, Kentaro Mori, Neuropsychopharmacology Complex MechanismFunctional SelectivityMedicineNeurotransmitterPharmacology	2014	200
Silibinin prevents amyloid β peptide‐induced memory impairment and oxidative stress in mice Ping Lü, Takayoshi Mamiya, LL Lu, British Journal of Pharmacology	2009	197
Neprilysin-sensitive Synapse-associated Amyloid-β Peptide Oligomers Impair Neuronal Plasticity and Cognitive Function Shu-Ming Huang, Akihiro Mouri, Hideko Kokubo, Journal of Biological Chemistry Synaptic TransmissionNeurochemical BiomarkersStructural PlasticitySynaptic SignalingAlzheimer's Disease	2006	175
Mice with neuron-specific accumulation of mitochondrial DNA mutations show mood disorder-like phenotypes Takaoki Kasahara, Mie Kubota, T. Miyauchi, Molecular Psychiatry Neurodegenerative DiseasesMolecular NeurosciencePsychiatryMood Disorder-like PhenotypesGenetics	2006	169
The Allosteric Potentiation of Nicotinic Acetylcholine Receptors by Galantamine Ameliorates the Cognitive Dysfunction in Beta Amyloid25–35 I.c.v.-Injected Mice: Involvement of Dopaminergic Systems Dayong Wang, Yukihiro Noda, Yuan Zhou, Neuropsychopharmacology Neurodegenerative DiseasesDopaminergic SystemsMedicineCognitive DysfunctionSynaptic Transmission	2006	147
Oral vaccination with a viral vector containing Aβ cDNA attenuates age‐related Aβ accumulation and memory deficits without causing inflammation in a mouse Alzheimer model Akihiro Mouri, Yukihiro Noda, Hideo Hara, The FASEB Journal ImmunologyImmunodominanceNeurochemical BiomarkersImmunotherapyNeuroinflammation	2007	142
Vulnerability in early life to changes in the rearing environment plays a crucial role in the aetiopathology of psychiatric disorders Minae Niwa, Yurie Matsumoto, Akihiro Mouri, The International Journal of Neuropsychopharmacology	2010	96
Identification of Novel Candidate Genes for Treatment Response to Risperidone and Susceptibility for Schizophrenia: Integrated Analysis Among Pharmacogenomics, Mouse Expression, and Genetic Case-Control Association Approaches Masashi Ikeda, Yasuyuki Tomita, Akihiro Mouri, Biological Psychiatry PsychiatryNovel Candidate GenesMedicineGeneticsPsychotropic Medication	2009	95
Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment Ping Lü, Takayoshi Mamiya, Lingling Lu, Behavioural Brain Research NeuropsychologyPsychoactive DrugCognitive NeuroscienceAddictionMedicine	2009	94
Involvement of a Dysfunctional Dopamine-D1/N-Methyl-d-aspartate-NR1 and Ca2+/Calmodulin-Dependent Protein Kinase II Pathway in the Impairment of Latent Learning in a Model of Schizophrenia Induced by Phencyclidine Akihiro Mouri, Yukihiro Noda, Akihiro Noda, Molecular Pharmacology	2007	93

Page 1